ArticleScientific reports2025
Research on recognition of diabetic retinopathy hemorrhage lesions based on fine tuning of segment anything model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Study on mmage defect recognition and classification of power transmission equipment based on lightweight model residual Mamba.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Diabetic Retinopathy (DR) demands precise hemorrhage detection for early diagnosis, yet manual identification faces challenges due to hemorrhagic lesions' varied sizes, complex shapes, and color similarities to surrounding tissues, which obscure boundaries and reduce contrast. To address this, we propose SAM-ada-Res, a novel dual-encoder model integrating a pre-trained Segment Anything Model (SAM) and ResNet101. SAM captures global semantic context to distinguish ambiguous lesions from vessels, while ResNet101 extracts fine-grained details through its deep hierarchical layers. Feature maps from both encoders are fused via channel-wise concatenation, enabling the decoder to localize lesions with high precision. A lightweight Adapter fine-tunes SAM for retinal tasks without retraining its backbone, ensuring task-specific adaptation. Evaluated on three datasets (OIA-DDR, IDRiD, JYFY-HE), SAM-ada-Res outperforms state-of-the-art methods in nDice (0.6040 on JYFY-HE) and nIoU (0.4182 on IDRiD), demonstrating superior generalization and robustness. An online platform further streamlines clinical deployment, enhancing diagnostic efficiency. By synergizing SAM's generalizable vision capabilities with ResNet's localized feature extraction, SAM-ada-Res overcomes key challenges in DR hemorrhage detection, offering a robust tool for early intervention. This work bridges technical innovation and clinical practicality, advancing automated DR diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.